Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.07464, expectations were $-0.17.
Source: insidermonkey.com
Greg Keenan News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Greg Keenan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Greg Keenan Today - Breaking & Trending Today
Long-Term Data, Renal Function Monitoring Update Added to Lupkynis Labeling
The updated label now includes 3-year data from AURORA 2, a double-blind, placebo-controlled extension study.
Source: empr.com
FDA Approves Voclosporin Label Update in Lupus Nephritis to Reflect Long-Term Data
FDA approves label update for voclosporin (Lupkynis) in lupus nephritis, reflecting long-term AURORA data and new kidney function monitoring guidance.
Source: hcplive.com
The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program
New data showing sustained complete renal response with LUPKYNIS through three years Monthly kidney function assessment no longer required after first year…
Source: financialpost.com
US Academy adopts AI detection platform to mitigate gun-related violence
ZeroEyes' gun detection and intelligent situational awareness solution has been used by Germantown Academy in Pennsylvania to protect students, staff, and visitors from gun-related violence.
Source: ifsecglobal.com